This new volume extends the debate initiated in The Economics of Essential Medicines by outlining the challenges in delivering essential medicines to developing countries. The contributors examines the extent to which the pharmaceutical industry can play a role in improving health service delivery and access to medicines in developing countries. They also discuss the impact of private-public partnerships and outlines specific efforts to bring medicines to developing countries. Contributors include Alexander S. Preker (Human Development Network, World Bank), Jim Attridge (Imperial College Management School, University of London), Goeran Ando (Pharmacia), Robert G. Ridley (World Health Organzation/TDR), and Jeffrey L. Sturchio (Merck & Company).